{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:55:25Z","timestamp":1790542525336,"version":"4.1.0"},"reference-count":123,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["14J06317"],"award-info":[{"award-number":["14J06317"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004051","name":"Kato Memorial Bioscience Foundation","doi-asserted-by":"publisher","award":["27B8"],"award-info":[{"award-number":["27B8"]}],"id":[{"id":"10.13039\/501100004051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00022","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T03:34:32Z","timestamp":1485315272000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases"],"prefix":"10.3389","volume":"8","author":[{"given":"Suguru","family":"Shigemori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Shimosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"46.e42","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"B2","first-page":"2727","article-title":"Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies","volume":"29","author":"Triantafillidis","year":"2009","journal-title":"Anticancer Res"},{"issue":"1","key":"B3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"B4","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3748\/wjg.v20.i12.3146","article-title":"Immunosuppressive therapies for inflammatory bowel disease","volume":"20","author":"Zenlea","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"B5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2036.2006.02786.x","article-title":"Review article: infliximab therapy for inflammatory bowel disease \u2013 seven years on","volume":"23","author":"Rutgeerts","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"B6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"B7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrgastro.2010.117","article-title":"Probiotics and the gut microbiota in intestinal health and disease","volume":"7","author":"Gareau","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"B8","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00253-015-6498-0","article-title":"Lactic acid bacteria \u2013 20 years exploring their potential as live vectors for mucosal vaccination","volume":"99","author":"Wyszynska","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"146972","DOI":"10.1155\/2015\/146972","article-title":"Current review of genetically modified lactic acid bacteria for the prevention and treatment of colitis using murine models","volume":"2015","author":"de Moreno de LeBlanc","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev-food-022510-133640","article-title":"Mucosal vaccination and therapy with genetically modified lactic acid bacteria","volume":"2","author":"Wells","year":"2011","journal-title":"Annu Rev Food Sci Technol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12934-015-0313-6","article-title":"Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes","volume":"14","author":"Cano-Garrido","year":"2015","journal-title":"Microb Cell Fact"},{"issue":"4","key":"B12","doi-asserted-by":"publisher","first-page":"G729","DOI":"10.1152\/ajpgi.00132.2007","article-title":"Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis","volume":"293","author":"Carroll","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"B13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/aem.03296-13","article-title":"Genetically engineered immunomodulatory Streptococcus thermophilus strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities","volume":"80","author":"Del Carmen","year":"2014","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"B14","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/01.mib.0000235101.09231.9e","article-title":"Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase","volume":"12","author":"Han","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"B15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jbiotec.2010.11.008","article-title":"Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn\u2019s disease in mice","volume":"151","author":"LeBlanc","year":"2011","journal-title":"J Biotechnol"},{"issue":"2","key":"B16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/1751-2980.12006","article-title":"Effect of recombinant Lactobacillus casei expressing interleukin-10 in dextran sulfate sodium-induced colitis mice","volume":"14","author":"Qiu","year":"2013","journal-title":"J Dig Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1475-2859-6-22","article-title":"Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice","volume":"6","author":"Rochat","year":"2007","journal-title":"Microb Cell Fact"},{"issue":"1","key":"B18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijfoodmicro.2010.03.037","article-title":"Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice","volume":"144","author":"Watterlot","year":"2010","journal-title":"Int J Food Microbiol"},{"issue":"2","key":"B19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1099\/jmm.0.000197","article-title":"Oral delivery of Bifidobacterium longum expressing \u03b1-melanocyte-stimulating hormone to combat ulcerative colitis","volume":"65","author":"Wei","year":"2016","journal-title":"J Med Microbiol"},{"issue":"6","key":"B20","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3109\/10717544.2015.1122672","article-title":"Oral Bifidobacterium longum expressing \u03b1-melanocyte-stimulating hormone to fight experimental colitis","volume":"23","author":"Wei","year":"2016","journal-title":"Drug Deliv"},{"issue":"2","key":"B21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/mp100331r","article-title":"Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum","volume":"8","author":"Yao","year":"2011","journal-title":"Mol Pharm"},{"issue":"12","key":"B22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1177\/1535370215584901","article-title":"Interleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell\/T helper 17 cell pathway","volume":"240","author":"Zhang","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"issue":"12","key":"B23","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.4014\/jmb.0800.445","article-title":"Lactobacillus casei secreting \u03b1-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb\/c Mice","volume":"18","author":"Yoon","year":"2008","journal-title":"J Microbiol Biotechnol"},{"issue":"10","key":"B24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/mt.2014.125","article-title":"A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation","volume":"22","author":"Whelan","year":"2014","journal-title":"Mol Ther"},{"issue":"6","key":"B25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.14712\/fb2012058060238","article-title":"Recombinant probiotic therapy in experimental colitis in mice","volume":"58","author":"Gardlik","year":"2012","journal-title":"Folia Biol (Praha)"},{"issue":"6","key":"B26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/jam.12461","article-title":"Superoxide dismutase recombinant Lactobacillus fermentum ameliorates intestinal oxidative stress through inhibiting NF-\u03baB activation in a trinitrobenzene sulphonic acid-induced colitis mouse model","volume":"116","author":"Hou","year":"2014","journal-title":"J Appl Microbiol"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0928-8244(03)00147-0","article-title":"Immunobiotics and the probiotic evolution","volume":"38","author":"Clancy","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B28","volume-title":"Probiotics: Immunobiotics and Immunogenics","author":"Kitazawa","year":"2014"},{"key":"B29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2014.00201","article-title":"Modulation of respiratory TLR3-anti-viral response by probiotic microorganisms: lessons learned from Lactobacillus rhamnosus CRL1505","volume":"5","author":"Kitazawa","year":"2014","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fimmu.2013.00512","article-title":"Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937","volume":"4","author":"Villena","year":"2014","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fimmu.2014.00421","article-title":"Regulation of toll-like receptors-mediated inflammation by immunobiotics in bovine intestinal epitheliocytes: role of signaling pathways and negative regulators","volume":"5","author":"Villena","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/microorganisms4030027","article-title":"Immunoregulatory effects triggered by lactic acid bacteria exopolysaccharides: new insights into molecular interactions with host cells","volume":"4","author":"Laino","year":"2016","journal-title":"Microorganisms"},{"key":"B33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12934-015-0198-4","article-title":"Serine protease inhibitors protect better than IL-10 and TGF-beta anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci","volume":"14","author":"Bermudez-Humaran","year":"2015","journal-title":"Microb Cell Fact"},{"issue":"3","key":"B34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.gastro.2007.06.018","article-title":"Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein","volume":"133","author":"Foligne","year":"2007","journal-title":"Gastroenterology"},{"issue":"5483","key":"B35","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"issue":"Suppl 1","key":"B36","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1097\/mcg.0000000000000235","article-title":"Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model","volume":"48","author":"del Carmen","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"B37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ibd.20346","article-title":"Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice","volume":"14","author":"Waeytens","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"B38","doi-asserted-by":"publisher","first-page":"210.e13","DOI":"10.1053\/j.gastro.2013.09.060","article-title":"Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice","volume":"146","author":"Hanson","year":"2014","journal-title":"Gastroenterology"},{"issue":"158","key":"B39","doi-asserted-by":"publisher","first-page":"158ra44","DOI":"10.1126\/scitranslmed.3004212","article-title":"Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis","volume":"4","author":"Motta","year":"2012","journal-title":"Sci Transl Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12934-015-0378-2","article-title":"Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice","volume":"14","author":"Shigemori","year":"2015","journal-title":"Microb Cell Fact"},{"issue":"5","key":"B41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1101\/gr.169701","article-title":"The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403","volume":"11","author":"Bolotin","year":"2001","journal-title":"Genome Res"},{"issue":"8","key":"B42","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1128\/jb.01768-06","article-title":"Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp. cremoris MG1363","volume":"189","author":"Wegmann","year":"2007","journal-title":"J Bacteriol"},{"issue":"11","key":"B43","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1128\/AEM.65.11.4881-4886.1999","article-title":"Survival, physiology, and lysis of Lactococcus lactis in the digestive tract","volume":"65","author":"Drouault","year":"1999","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"B44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1139\/w03-092","article-title":"Survival of lactococci during passage through mouse digestive tract","volume":"49","author":"Kimoto","year":"2003","journal-title":"Can J Microbiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12934-015-0367-5","article-title":"Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model","volume":"14","author":"Aubry","year":"2015","journal-title":"Microb Cell Fact"},{"key":"B46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12896-016-0255-z","article-title":"Recombinant Lactococcus lactis expressing porcine insulin-like growth factor I ameliorates DSS-induced colitis in mice","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Biotechnol"},{"issue":"3","key":"B47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","article-title":"Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease","volume":"65","author":"Quevrain","year":"2016","journal-title":"Gut"},{"issue":"5","key":"B48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2174\/1389201015666141113123502","article-title":"Milk fermented with a 15-lipoxygenase-1-producing Lactococcus lactis alleviates symptoms of colitis in a murine model","volume":"16","author":"Saraiva","year":"2015","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"B49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/mi.2009.116","article-title":"Orally administered L. lactis secreting an anti-TNF nanobody demonstrate efficacy in chronic colitis","volume":"3","author":"Vandenbroucke","year":"2010","journal-title":"Mucosal Immunol"},{"issue":"2","key":"B50","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.gastro.2004.05.020","article-title":"Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice","volume":"127","author":"Vandenbroucke","year":"2004","journal-title":"Gastroenterology"},{"issue":"7","key":"B51","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1440-1746.2012.07158.x","article-title":"Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis","volume":"27","author":"Wong","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"B52","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","article-title":"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease","volume":"4","author":"Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"B53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrmicro1840","article-title":"Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria","volume":"6","author":"Wells","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"B55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"issue":"4","key":"B56","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1084\/jem.187.4.571","article-title":"The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor","volume":"187","author":"Spencer","year":"1998","journal-title":"J Exp Med"},{"issue":"9748","key":"B57","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/s0140-6736(10)61008-2","article-title":"Infant colitis \u2013 it\u2019s in the genes","volume":"376","author":"Glocker","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"B58","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"B59","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nbt840","article-title":"Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10","volume":"21","author":"Steidler","year":"2003","journal-title":"Nat Biotechnol"},{"issue":"4","key":"B60","doi-asserted-by":"publisher","first-page":"G568","DOI":"10.1152\/ajpgi.00329.2010","article-title":"Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells","volume":"300","author":"Sasaoka","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"B61","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/ng.489","article-title":"Common variants at five new loci associated with early-onset inflammatory bowel disease","volume":"41","author":"Imielinski","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"B62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"Abraham","year":"2008","journal-title":"Pharmacol Rev"},{"issue":"1","key":"B63","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbrc.2005.08.020","article-title":"Heme oxygenase and heme degradation","volume":"338","author":"Kikuchi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"39","key":"B64","doi-asserted-by":"publisher","first-page":"26847","DOI":"10.1074\/jbc.M114.590554","article-title":"Heme oxygenase-1 ameliorates dextran sulfate sodium-induced acute murine colitis by regulating Th17\/Treg cell balance","volume":"289","author":"Zhang","year":"2014","journal-title":"J Biol Chem"},{"issue":"5","key":"B65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"issue":"5","key":"B66","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"issue":"4","key":"B67","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1053\/j.gastro.2004.01.012","article-title":"A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn\u2019s disease","volume":"126","author":"Ito","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"B68","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00253-016-7907-8","article-title":"Secretion of an immunoreactive single-chain variable fragment antibody against mouse interleukin 6 by Lactococcus lactis","volume":"101","author":"Shigemori","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"B69","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ajg.2008.118","article-title":"Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis","volume":"104","author":"Miele","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"B70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2036.2011.04939.x","article-title":"Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis","volume":"35","author":"Oliva","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"B71","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cgh.2009.07.016","article-title":"The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis","volume":"7","author":"Sood","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"B72","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/ajg.2010.218","article-title":"Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study","volume":"105","author":"Tursi","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"B73","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MCG.0b013e3182549092","article-title":"World gastroenterology organisation global guidelines: probiotics and prebiotics October 2011","volume":"46","author":"Guarner","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"B74","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3748\/wjg.v13.i2.236","article-title":"Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria","volume":"13","author":"Foligne","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"B75","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00210-014-0985-1","article-title":"Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases","volume":"387","author":"Piechota-Polanczyk","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"874610","DOI":"10.1155\/2014\/874610","article-title":"\u03b1-Melanocyte stimulating hormone: an emerging anti-inflammatory antimicrobial peptide","volume":"2014","author":"Singh","year":"2014","journal-title":"Biomed Res Int"},{"issue":"2","key":"B77","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-2249.2011.04496.x","article-title":"Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure","volume":"167","author":"Donkor","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"B78","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2249.2011.04408.x","article-title":"Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages","volume":"165","author":"Latvala","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"B79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2010.02.110","article-title":"CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via toll-like receptor 9","volume":"394","author":"Shimosato","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"B80","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1740-0929.2009.00680.x","article-title":"Identification of a potent immunostimulatory oligodeoxynucleotide from Streptococcus thermophilus lacZ","volume":"80","author":"Shimosato","year":"2009","journal-title":"Anim Sci J"},{"key":"B81","doi-asserted-by":"publisher","first-page":"378417","DOI":"10.1155\/2011\/378417","article-title":"Streptococcus thermophilus ST28 ameliorates colitis in mice partially by suppression of inflammatory Th17 cells","volume":"2011","author":"Ogita","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"B82","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3892\/ijmm.2011.755","article-title":"Suppression of Th17 response by Streptococcus thermophilus ST28 through induction of IFN-\u03b3","volume":"28","author":"Ogita","year":"2011","journal-title":"Int J Mol Med"},{"issue":"5","key":"B83","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4161\/hv.28155","article-title":"rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant","volume":"10","author":"Petrarca","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"B84","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1099\/jmm.0.000323","article-title":"Evaluation of the biosafety of recombinant lactic acid bacteria designed to prevent and to treat colitis","volume":"65","author":"de Moreno de LeBlanc","year":"2016","journal-title":"J Med Microbiol"},{"issue":"6641","key":"B85","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/bmj.297.6641.102","article-title":"Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea","volume":"297","author":"Burke","year":"1988","journal-title":"BMJ"},{"issue":"1","key":"B86","first-page":"9","article-title":"Intestinal bacteria and ulcerative colitis","volume":"4","author":"Cummings","year":"2003","journal-title":"Curr Issues Intest Microbiol"},{"issue":"3","key":"B87","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn\u2019s disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"12","key":"B88","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1086\/420823","article-title":"Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis","volume":"38","author":"Macfarlane","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"B89","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.MIB.0000159663.62651.4f","article-title":"Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease","volume":"11","author":"Mylonaki","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"B90","doi-asserted-by":"publisher","first-page":"e1002714","DOI":"10.1371\/journal.ppat.1002714","article-title":"Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon","volume":"8","author":"Jeon","year":"2012","journal-title":"PLoS Pathog"},{"issue":"7","key":"B91","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/gut.52.7.975","article-title":"Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance","volume":"52","author":"McCarthy","year":"2003","journal-title":"Gut"},{"issue":"7","key":"B92","doi-asserted-by":"publisher","first-page":"e0134050","DOI":"10.1371\/journal.pone.0134050","article-title":"Bifidobacterium longum CCM 7952 promotes epithelial barrier function and prevents acute DSS-induced colitis in strictly strain-specific manner","volume":"10","author":"Srutkova","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"B93","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/ibd.20861","article-title":"Upregulation of T-bet and tight junction molecules by Bifidobacterium longum improves colonic inflammation of ulcerative colitis","volume":"15","author":"Takeda","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"B94","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1286-4579(02)00080-1","article-title":"Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients","volume":"5","author":"Setoyama","year":"2003","journal-title":"Microbes Infect"},{"issue":"42","key":"B95","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1073\/pnas.1011737107","article-title":"Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes","volume":"107","author":"Veiga","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"B96","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4161\/gmic.20358","article-title":"Portrait of an immunoregulatory Bifidobacterium","volume":"3","author":"Konieczna","year":"2012","journal-title":"Gut Microbes"},{"issue":"3","key":"B97","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/gutjnl-2011-300936","article-title":"Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells","volume":"61","author":"Konieczna","year":"2012","journal-title":"Gut"},{"issue":"8","key":"B98","doi-asserted-by":"publisher","first-page":"e1000112","DOI":"10.1371\/journal.ppat.1000112","article-title":"Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-\u03baB activation","volume":"4","author":"O\u2019Mahony","year":"2008","journal-title":"PLoS Pathog"},{"issue":"3","key":"B99","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","article-title":"Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles","volume":"128","author":"O\u2019Mahony","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"B100","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/gmic.25487","article-title":"Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut","volume":"4","author":"Groeger","year":"2013","journal-title":"Gut Microbes"},{"issue":"1","key":"B101","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/den.12553","article-title":"Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: a randomized, double-blinded, placebo-controlled multicenter trial","volume":"28","author":"Tamaki","year":"2016","journal-title":"Dig Endosc"},{"issue":"7","key":"B102","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"B103","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1365-2036.2004.02268.x","article-title":"Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis","volume":"20","author":"Kato","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3109\/08910600903444267","article-title":"The non-pathogenic Escherichia coli strain Nissle 1917 \u2013 features of a versatile probiotic","volume":"21","author":"Sonnenborn","year":"2009","journal-title":"Microb Ecol Health Dis"},{"issue":"11","key":"B105","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"issue":"5","key":"B106","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","article-title":"Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis","volume":"11","author":"Kruis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"9179","key":"B107","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"B108","doi-asserted-by":"publisher","first-page":"e1308","DOI":"10.1371\/journal.pone.0001308","article-title":"Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity","volume":"2","author":"Ukena","year":"2007","journal-title":"PLoS One"},{"issue":"3","key":"B109","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1099\/jmm.0.000222","article-title":"Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model","volume":"65","author":"Souza","year":"2016","journal-title":"J Med Microbiol"},{"issue":"2","key":"B110","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1128\/cdli.11.2.372-378.2004","article-title":"Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis","volume":"11","author":"Schultz","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"B111","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/01.MIB.0000158158.55955.de","article-title":"Nonpathogenic Escherichia coli strain Nissle 1917 prevents murine acute and chronic colitis","volume":"11","author":"Kamada","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"20","key":"B112","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1007\/s00253-016-7829-5","article-title":"Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application","volume":"100","author":"Ou","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1\u20132","key":"B113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijmm.2007.08.008","article-title":"Development of a tripartite vector system for live oral immunization using a Gram-negative probiotic carrier","volume":"298","author":"Buddenborg","year":"2008","journal-title":"Int J Med Microbiol"},{"issue":"34","key":"B114","doi-asserted-by":"publisher","first-page":"11993","DOI":"10.1073\/pnas.0504881102","article-title":"Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide","volume":"102","author":"Rao","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"B115","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ijmm.2009.03.003","article-title":"Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88","volume":"299","author":"Remer","year":"2009","journal-title":"Int J Med Microbiol"},{"issue":"3\u20134","key":"B116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpara.2012.10.014","article-title":"A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation","volume":"43","author":"Danilowicz-Luebert","year":"2013","journal-title":"Int J Parasitol"},{"issue":"1","key":"B117","doi-asserted-by":"publisher","first-page":"e1001248","DOI":"10.1371\/journal.ppat.1001248","article-title":"A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages","volume":"7","author":"Klotz","year":"2011","journal-title":"PLoS Pathog"},{"issue":"5","key":"B118","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1128\/IAI.71.5.2422-2429.2003","article-title":"Parasite-specific immunomodulatory functions of filarial cystatin","volume":"71","author":"Schierack","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"B119","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.4049\/jimmunol.180.6.4265","article-title":"A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages","volume":"180","author":"Schnoeller","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"B120","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejpb.2004.09.003","article-title":"Evaluation of extrusion\/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis","volume":"59","author":"Huyghebaert","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"B121","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ejpb.2005.02.012","article-title":"Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10","volume":"60","author":"Huyghebaert","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"issue":"24","key":"B122","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1002\/cncr.28365","article-title":"Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy","volume":"119","author":"Limaye","year":"2013","journal-title":"Cancer"},{"issue":"Suppl 1","key":"B123","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1475-2859-13-s1-s11","article-title":"Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the type 1 diabetes case","volume":"13","author":"Robert","year":"2014","journal-title":"Microb Cell Fact"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T19:34:26Z","timestamp":1749929666000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":123,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00022","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]}}}